Several components of the immune system are involved in the host response to acute viral infections. The activation of macrophages (1) , natural killer cells (22) , lymphocytes (6) , and the production of interferon (17) , and anti-viral antibody (18) all appear to play a role in the response. The significance of in vitro correlates of the immune response to viral infections as well as how the components of the immune system interact to clear viral infections is not clear.
Studies in this laboratory have been aimed at understanding the immune response to Sindbis virus infection in mice. Sindbis virus, an alphavirus of the togavirus group, causes an acute encephalitis in mice, in which mortality is age dependent (7, 11, 19) . A mononuclear cell inflammatory response is observed 4 to 8 days after infection. This response appears to be specific, since Sindbis virus-sensitized lymphocytes, but not immune serum, can transfer this response to immunosuppressed, infected hosts. Bone marrow cells enhance the inflammatory response (16) .
To investigate the role of the immune response in recovery from Sindbis virus encephalitis a neuroadapted strain of Sindbis virus (NSV) was developed (9) . Unlike tissue culturegrown virus, NSV causes fatal encephalitis in weanling mice. Animals can be protected from a fatal NSV infection by passive transfer of immune serum 24 h after intracerebral infection.
Sensitized lymphocytes are not protective. The protective factor in immune serum is immunoglobulin G (IgG) and protection is not solely a function of transfer of neutralizing antibody: serum-treated animals did not have significantly lowered amounts of brain virus, certain fractions of serum with high viral neutralization activity were not protective, and cyclophosphamide treatment of animals abolished the protective capacity of serum, indicating that a host cell was also required for antibody protection (9) . The studies presented here further explored the characteristics of the protective serum, and the effect of immune serum on lymphocyte effector functions in vitro and the host factors required for its effect. Virus. NSV was prepared as described previously (9) (20) . Complement depletion of CoVF-treated mice was confirmed by assessment of serum C3 levels (10) .
Preparation of lymphocytes for cytotoxicity testing. Spleens and axillary, brachial, and popliteal lymph nodes from 6-to 8-week old mice were removed aseptically and placed in RPMI-1640 (Gibco, Grand Island, N.Y.) medium containing 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), and supplemented with 5% FCS (Microbiological Associates, Walkersville, Md.). Lymph nodes were teased apart with 26-guage needles, and the released cells were washed three times with RPMI before in vitro culture. Spleen cells were teased apart with 26-gauge needles, and lymphocytes were obtained from the suspension by separation on Ficoll-Hypaque (2).
Modification of effector cell populations. Adherent cells were removed from LNC suspensions by the method of Vassar et al. (21) . A total of 10 to 15% of LNC suspensions were adherent by this method. Treatment of LNC suspensions with anti-Thy 1.2 serum and complement was performed as described previously (8) .
Modification of serum. Heat-killed, Formalinfixed Staphylococcus aureus containing protein A was prepared by the method of Jonsson and Kronvall (12) , and absorption of mouse serum with this preparation was performed as previously described (13) . Levels of immunoglobulin before and after absorption were quantitated by radial immunodiffusion by using monospecific antiserum to mouse IgG subclasses (Miles Labs, Elkhardt, Ind.). IgG2a, -2b, and -3 were no longer detectable after absorption.
F(ab)'2 fragments of mouse immunoglobulin were prepared as described previously (5) with the exception that pepsin digestion was performed on 50% (NH4)2SO4 precipitates of mouse serum, and the reaction was performed at pH 4.9. The antigen binding capacity of F(ab)'2 fragments was intact as shown by the ability to inhibit cell-mediated cytotoxicity (CMC). In addition, F(ab)'2 preparations did not fix complement in complement fixation assays with Sindbis virus antigen.
CMC assay. Previous studies indicated that LNC from Sindbis virus-infected mice were cytotoxic for virus-infected primary murine fibroblasts (15) . In the current study, BALB/c 3T3 clone A-31 cells were used as targets. A portion of 104 cells on flat-bottom microtiter plates (Falcon no. 3042) was infected with NSV for 1 h at 370C. The multiplicity of infection was 2. At 3 h after infection 1 LCi of 51Cr (Na25"CrO4, Amer- sham/Searle, specific activity 1 Ci/mM) in 0.2 ml of HBSS containing 5% FCS was added to each well for 1 h at 370C.
It was found that LNC and splenic lymphocytes obtained from animals 6 days after footpad inoculation with 105 PFU of NSV were cytotoxic towards Sindbisinfected 3T3 cells (effector-to-target-cell ratio, E/T = 50). (Approximately 90% of target cells showed viral antigen on the cell surface as determined by indirect fluorescent microscopy of live cells 7 h after infection). Cytotoxic activity was maximum 18 h after addition of LNC (22 h after infection of target cells). Due to the lytic nature of Sindbis virus infection, low levels of cytotoxicity were observed at 24 to 26 h after infection as a result of the increase in "spontaneous" 61Cr release. Thus, all subsequent assays were evaluated 22 h after target cell infection.
In experiments in which the effects of anti-NSV serum were tested, 0.2 ml of heat-inactivated serum was added for 1 (Table 1) . Effect of anti-Sindbis serum on CMC. To test the hypothesis (9) that antibody (Ab)-mediated protection may be mediated by the inhibition of T-cell cytotoxicity, anti-NSV serum was evaluated for effects on lymphoid cell effector function and ability to protect in vitro and in vivo. Mouse LNC or splenic lymphocytes obtained from mice 6 days after footpad inoculation of NSV were cytotoxic for Sindbis virusinfected 3T3 cells. Cytotoxicity was abolished by treatment with anti-Thy 1.2 serum and complement; removal of adherent cells did not affect cytotoxicity. Sera obtained from mice at various times after footpad inoculation of NSV were investigated for effects on lysis of infected target cells. Antiserum collected 6 or more days after NSV infection significantly inhibited lysis of infected cells by sensitized spleen cells or LNC (Fig. 1) . Antiserum taken at 8 and 12 days after infection was markedly inhibitory and protective. The inhibition was dose dependent, and at 1/500 dilution no inhibition was observed. Treatment of cells with normal mouse serum did not inhibit cytotoxicity. When nonsensitized splenic lymphocytes or LNC were applied to serumtreated, infected targets, no enhancement of cytotoxicity was observed (Table 2) . Furthermore, 2-ME treatment of serum did not decrease the inhibitory capacity ofserum, indicating that IgM was not responsible for inhibition.
Host cell requirements. Previous studies (9) showed that cyclophosphamide-treated, infected hosts could not be protected with Ab. Animals treated with cyclophosphamide were not protected by 12-day serum, even if serum was given repeatedly (every 2 days) ( Table 3 ). To evaluate the host cellular component required for protection, cell transfer studies were carried out in cyclophosphamide-immunosuppressed hosts. LNC obtained from donors 6 days after footpad inoculation, or from uninoculated mice, were injected i.p. along with 12-day anti-NSV serum, 24 h after virus inoculation. LNC did not restore the cyclophosphamide-sensitive cell population required for Ab-mediated protection (Table 3) . Furthermore, nude mice were equally sensitive to NSV infection (same LD50) and could be protected by Ab alone (Table 3) .~5 
DISCUSSION
These studies confirm and extend previous results which showed that anti-NSV IgG protects animals from fatal NSV encephalitis. We have shown that the inhibition of T-cell-mediated cytotoxicity by anti-NSV Ab, although correlating with protection, does not relate to the mechanism by which Ab exerts its effect in vivo. Nude mice, which were equally sensitive to NSV encephalitis, could be protected by Ab even though lacking T cells. This indicates that the phenomenon of Ab inhibition of T-cell cytotoxicity in vitro does not explain the in vivo protection in this system. Furthermore, the fact that 5 x 107 sensitized or normal LNC could not restore the cyclophosphamide-sensitive cell population, required along with Ab for protection, indicates that another cell population is necessary for protection and possible interaction with ance ofvirus, and that the transfer of this inflammatory response to cyclophosphamide-treated mice by specifically sensitized lymphocytes could be enhanced with bone marrow cells (16) . Perhaps a population of cells within the marrow is required for the Ab-mediated protection observed in this system.
Our studies with F(ab)'2 preparations of anti-NSV Ab indicate that an Fc-dependent IgG function is necessary at some point for protection. Complement-mediated mechanisms seem unlikely since depletion of C3 by CoVF treatment of infected animals did not change the protective capacity of Ab. Alternatively, the Fc piece of IgG may be required for transfer of immunoglobulin across the blood-brain barrier or for efficient processing of opsonized virus.
Antibody-dependent cellular cytotoxicity is another possible Fc-dependent IgG-mediated mechanism which could operate in protection. The murine macrophage has been shown to mediate antibody-dependent cellular cytotoxicity against cells infected with Semliki Forest virus (14) , another alpha-togavirus. Although we have not yet been able to demonstrate antibodydependent cellular cytotoxicity against Sindbisinfected cells, macrophage-enriched populations have not been tested. The transfer of anti-NSV IgG to infected hosts allows for the presence of specific anti-viral Ab 2 to 3 days before detection of Ab in untreated, infected animals. The presence of this Ab could mediate protection by coating infected cells in the brain and, in the presence of the mononuclear cell infiltrate, infected cells could be eliminated. The elimination of infected cells early in the infection could limit viral replication in the brain and resolve an otherwise fatal infection.
